Pharmacologic Therapy of Benign Prostatic Hyperplasia Flashcards
Benign Prostatic Hyperplasia
- Abnormal enlargement of the prostate gland that appears to occur with aging
- Produces persistant lower urinary tract symptoms (LUTS)
Prostate Gland
- Walnut-sized gland located between bladder and penis
- Urethra runs through center of the prostate
- Prostate secretes fluid that nourishes and protects sperm
What are the three types of prostate tissue?
- Epithelial
- Stromal
- Capsule
Epithelial tissue
- Glandular tissue
- Produces ejaculate secretions
Stromal tissue
- Smooth muscle tissue
- Contains **alpha-1 adrenergic receptors **
Capsule tissue
- Outer shell
- Compromised of fibrous connective tissue with alpha-1 adrenergic receptors
5-alpha reductase
Converts testosterone and androstenedione to dihydrotestosterone (DHT) which causes prostate enlargement and growth
What are some obstructive symptoms of BPH?
- Hesitancy
- Dribbling
- Incomplete emptying
- Interrupted stream
- Impaired force or size of urinary stream
- Strain or push to urinate
- acute retention
What are some irritative symptoms of BPH?
- Frequency
- Urgency
- Nocturia
- Pain or burning on urination
What are the complications of BPH?
- Urinary retention
- Overflow urinary incontinence
- Renal insufficiency
- Urinary tract infection
- Gross hematuria
- Bladder stones
What is used to screen for prostate cancer?
Prostate specific antigen (PSA) and digital rectal exam (DRE)
* PSA > 1.4 ng/mL –> at risk for developing complications of disease
What is the peak and average urinary flow rate?
10-15 mL/sec
What are some medications that can exacerbate symptoms of BPH?
- Anticholinergics
- Bronchodilators
- Psychotropics
- Antidepressants that have anticholinergic effects
- Antiarrhythmics/antianginals that have anticholinergic effects
- Antihistamines
- OTC medications – cough and cold
What are some treatment options?
- Watchful waiting
- Behavorial interventions
- Surgery
- Prostatectomy (transurethrally “TURP” or suprapubically)
- Balloon dilation
- Pharmacologic options
- Alpha-adrenergic blockade
- 5-alpha reductase inhibition
- Phosphodiesterase-5 (PDE-5) inhibitors
Alpha-1 antagonist
- MOA: Blockade alpha-1 adrenergic receptors in the prostatic stromal tissue
- Faster at reducing LUTS
- **Do NOT reproduce prostate size **
- NO effect on PSA
- SLOW titration to treatment maintenance dose is needed
- No dosage reduction in renal failure
- Should NOT be used as a single agent in patients with BPH and HTN (ALLHAT trials)